Catalio Capital Management LP insider trades
Open-market stock purchases and sales by Catalio Capital Management LP, 10% Owner at Iambic Therapeutics, Inc, from SEC Form 4 filings since Oct 16, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 16, 2026 | IAM Iambic Therapeutics, Inc | Bought (not open market) | — |
| Oct 16, 2026 | IAM Iambic Therapeutics, Inc | Bought (not open market) | — |
| Oct 16, 2026 | IAM Iambic Therapeutics, Inc | Bought (not open market) | — |
| Oct 16, 2026 | IAM Iambic Therapeutics, Inc | Bought (not open market) | — |
| Oct 16, 2026 | IAM Iambic Therapeutics, Inc | Bought (not open market) | — |
| Oct 16, 2026 | IAM Iambic Therapeutics, Inc | Bought (not open market) | — |
| Oct 16, 2026 | IAM Iambic Therapeutics, Inc | Bought (not open market) | — |
| Oct 16, 2026 | IAM Iambic Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- IAM Iambic Therapeutics, Inc: other filings, last Oct 16, 2026
Get free alerts when Catalio Capital Management LP files a new trade →